Logo image of CMO

Capstead Mortgage Corp (CMO) Stock Fundamental Analysis

NYSE:CMO - New York Stock Exchange, Inc. -

6.5  +0.16 (+2.52%)

After market: 6.55 +0.05 (+0.77%)

Fundamental Rating

1

Overall CMO gets a fundamental rating of 1 out of 10. We evaluated CMO against 65 industry peers in the Mortgage Real Estate Investment Trusts (REITs)" industry. Both the profitability and financial health of CMO have multiple concerns. CMO does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CMO was profitable.

1.2 Ratios

Industry RankSector Rank
ROA 1.11%
ROE 9.95%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 89.2%
PM (TTM) 74.91%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

0

2. Health

2.1 Basic Checks

There is no outstanding debt for CMO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

CMO has a Debt/Equity ratio of 7.91. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 7.91
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

More info and screens

1

3. Growth

3.1 Past

CMO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.67%.
The Earnings Per Share has been decreasing by -7.88% on average over the past years.
CMO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -57.19%.
The Revenue has been decreasing by -2.90% on average over the past years.
EPS 1Y (TTM)-11.67%
EPS 3Y0.52%
EPS 5Y-7.88%
EPS Q2Q%-50%
Revenue 1Y (TTM)-57.19%
Revenue growth 3Y-7.17%
Revenue growth 5Y-2.9%
Sales Q2Q%-56.83%

3.2 Future

The Earnings Per Share is expected to grow by 1.36% on average over the next years.
The Revenue is expected to decrease by -7.18% on average over the next years.
EPS Next Y-2.11%
EPS Next 2Y3.92%
EPS Next 3Y0.84%
EPS Next 5Y1.36%
Revenue Next Year-39.38%
Revenue Next 2Y-19.44%
Revenue Next 3Y-13.42%
Revenue Next 5Y-7.18%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CMO Yearly Revenue VS EstimatesCMO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
CMO Yearly EPS VS EstimatesCMO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 12.26, the valuation of CMO can be described as correct.
CMO is valuated cheaply when we compare the Price/Earnings ratio to 24.85, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 9.26, the valuation of CMO can be described as reasonable.
CMO's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 20.89.
Industry RankSector Rank
PE 12.26
Fwd PE 9.26
CMO Price Earnings VS Forward Price EarningsCMO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 38.02
CMO Per share dataCMO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.92%
EPS Next 3Y0.84%

More info and screens

1

5. Dividend

5.1 Amount

With a yearly dividend of 0.77%, CMO is not a good candidate for dividend investing.
With a Dividend Yield of 0.77, CMO pays less dividend than the S&P500 average, which is at 2.40.
Industry RankSector Rank
Dividend Yield 0.77%

5.2 History

The dividend of CMO decreases each year by -40.61%.
CMO has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)-40.61%
Div Incr YearsN/A
Div Non Decr YearsN/A
CMO Yearly Dividends per shareCMO Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 0.2 0.4 0.6 0.8 1

5.3 Sustainability

88.97% of the earnings are spent on dividend by CMO. This is not a sustainable payout ratio.
DP88.97%
EPS Next 2Y3.92%
EPS Next 3Y0.84%
CMO Dividend Payout.CMO Dividend Payout, showing the Payout Ratio.CMO Dividend Payout.PayoutRetained Earnings

More info and screens

Capstead Mortgage Corp

NYSE:CMO (10/18/2021, 8:43:55 PM)

After market: 6.55 +0.05 (+0.77%)

6.5

+0.16 (+2.52%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryMortgage Real Estate Investment Trusts (REITs)"
Earnings (Last)10-27 2021-10-27
Earnings (Next)01-11 2022-01-11
Inst Owners0.91%
Inst Owner Change0%
Ins Owners0.8%
Ins Owner Change0%
Market Cap629.69M
Analysts100
Price Target6.97 (7.23%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.77%
Yearly Dividend0.05
Dividend Growth(5Y)-40.61%
DP88.97%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 12.26
Fwd PE 9.26
P/S 5.43
P/FCF N/A
P/OCF N/A
P/B 0.72
P/tB N/A
EV/EBITDA 38.02
EPS(TTM)0.53
EY8.15%
EPS(NY)0.7
Fwd EY10.8%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.2
BVpS9.01
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.11%
ROE 9.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 89.2%
PM (TTM) 74.91%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 7.91
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.67%
EPS 3Y0.52%
EPS 5Y-7.88%
EPS Q2Q%-50%
EPS Next Y-2.11%
EPS Next 2Y3.92%
EPS Next 3Y0.84%
EPS Next 5Y1.36%
Revenue 1Y (TTM)-57.19%
Revenue growth 3Y-7.17%
Revenue growth 5Y-2.9%
Sales Q2Q%-56.83%
Revenue Next Year-39.38%
Revenue Next 2Y-19.44%
Revenue Next 3Y-13.42%
Revenue Next 5Y-7.18%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A